+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Enzalutamide Tablets Market - Global Forecast 2025-2030- Product Image
Enzalutamide Tablets Market - Global Forecast 2025-2030- Product Image
Sale

Enzalutamide Tablets Market - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 186 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 6118173
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Enzalutamide tablet market is undergoing rapid transformation as breakthrough therapies, evolving regulatory environments, and shifting patient expectations redefine competitive strategies. This report delivers a concise and actionable overview, providing senior decision-makers with an in-depth analysis of the multi-faceted drivers, segmentation, and regulatory dynamics shaping market opportunities and risks.

Market Snapshot: Enzalutamide Tablet Global Outlook

Enzalutamide tablets have become a cornerstone in prostate cancer therapy, with the market showing strong momentum and an impressive CAGR, driven by increased adoption worldwide. Expanded approvals in key adjudicated geographies and rising demand for targeted androgen receptor inhibitors position enzalutamide tablets for robust market performance.

Scope & Segmentation

  • Therapy Lines: First-line, second-line, and third-line therapies, addressing different stages of prostate cancer progression and distinct patient needs.
  • End Users: Hospital pharmacies, retail pharmacies, government and private hospitals, chain and independent pharmacies, oncology and urology specialty clinics.
  • Indications: Metastatic castration-resistant prostate cancer, metastatic hormone-sensitive prostate cancer, and non-metastatic castration-resistant prostate cancer.
  • Distribution Channels: Direct tender (national and regional), hospital pharmacy purchase (direct procurement, public tenders), manufacturer websites, and third-party online platforms.
  • Dosage Strengths: 40 mg, 80 mg, 120 mg, and 160 mg tablets, aligned with diverse prescribing regimens and patient profiles.
  • Geographies: Americas (including United States, Canada, Mexico, Brazil, Argentina), Europe, Middle East, Africa (covering United Kingdom, Germany, UAE, Saudi Arabia), and Asia-Pacific regions (China, India, Japan, Australia, Southeast Asian countries).
  • Key Companies: Major industry participants include Astellas Pharma Inc., Pfizer Inc., Teva Pharmaceutical Industries Ltd., Sandoz International GmbH, Dr. Reddy’s Laboratories Ltd., Aurobindo Pharma Ltd., Sun Pharmaceutical Industries Ltd., Lupin Limited, Cipla Limited, and Hetero Labs Limited.

Key Takeaways

  • Real-world evidence, driven by collaborations between pharmaceutical manufacturers and healthcare providers, is emerging as a differentiator in payer negotiations and treatment accessibility.
  • Digital health initiatives increasingly support remote adherence tracking and customized patient support, contributing to improved therapeutic outcomes and higher uptake.
  • Expanded payer scrutiny and evolving guidelines are influencing both formulary decisions and reimbursement structures in established and emerging markets.
  • Entry of biosimilars and pipeline agents is intensifying competitive dynamics, prompting manufacturers to explore combination regimens and novel delivery methods for sustained differentiation.
  • Strategic alliances between pharma companies and specialty clinics foster the initiation of innovative clinical trials and accelerate access to combination therapies.
  • Operational agility is key, as organizations navigate complex procurement cycles, regional infrastructure differences, and evolving regulatory requirements.

Tariff Impact: United States 2025 Tariff Adjustments

Forthcoming tariff changes in the United States are expected to reshape the enzalutamide tablet supply chain. Increased costs for imported active pharmaceutical ingredients may alter sourcing and manufacturing decisions, leading stakeholders to consider nearshoring and diversification of procurement. Logistics, distributor negotiations, and compliance processes will require enhanced oversight to minimize disruptions. Dynamic pricing models and value-based contracting are gaining prominence as companies seek to balance upward cost pressures with the need for patient access. Strategic risk management, in conjunction with streamlined supplier partnerships, remains vital for supply chain continuity.

Methodology & Data Sources

This research adopts a multi-faceted approach, integrating in-depth interviews with oncologists, payers, and distributors alongside a comprehensive review of regulatory filings and corporate disclosures. Quantitative modeling assesses supply, procurement, and pricing trends, while thematic qualitative insights deepen understanding of access barriers and therapy adoption. Data triangulation and independent peer review ensure robust, validated findings.

Why This Report Matters

  • Enables confident, data-driven decision-making on product positioning, investment, and pricing strategies in the enzalutamide tablet sector.
  • Supports risk mitigation and opportunity identification through detailed segmentation, competitive analysis, and regional performance insights.
  • Facilitates the alignment of cross-functional teams to evolving industry trends, payer requirements, and patient-centric approaches.

Conclusion

This report synthesizes actionable insights to help decision-makers anticipate transformation in the enzalutamide tablet market. Strategic foresight, operational agility, and collaborative partnerships will be essential to capitalize on evolving opportunities and sustain growth.



This product will be delivered within 1-3 business days.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Impact of novel patent expirations on Enzalutamide market exclusivity and generic entry timelines
5.2. Real-world evidence studies assessing cardiovascular risk associated with long-term Enzalutamide therapy
5.3. Shifts in prescribing patterns due to updated prostate cancer treatment guidelines favoring Enzalutamide first line
5.4. Competitive pressure from emerging androgen receptor inhibitors in phase III clinical trials for prostate cancer
5.5. Pricing strategies adapting to healthcare reimbursement challenges for high-cost Enzalutamide tablets
5.6. Patient adherence barriers identified in long-term oral Enzalutamide regimens for mCRPC patients
5.7. Integration of genomic companion diagnostics to personalize Enzalutamide therapy in advanced prostate cancer patients
5.8. Regional variations in Enzalutamide adoption driven by differing regulatory approvals and payer access pathways
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Enzalutamide Tablets Market, by Therapy Line
8.1. Introduction
8.2. First-Line Therapy
8.3. Second-Line Therapy
8.4. Third-Line Therapy
9. Enzalutamide Tablets Market, by End User
9.1. Introduction
9.2. Hospital Pharmacies
9.2.1. Government Hospitals
9.2.2. Private Hospitals
9.3. Retail Pharmacies
9.3.1. Chain Pharmacies
9.3.2. Independent Pharmacies
9.4. Specialty Clinics
9.4.1. Oncology Clinics
9.4.2. Urology Clinics
10. Enzalutamide Tablets Market, by Indication
10.1. Introduction
10.2. Metastatic Castration-Resistant Prostate Cancer
10.3. Metastatic Hormone-Sensitive Prostate Cancer
10.4. Non-Metastatic Castration-Resistant Prostate Cancer
11. Enzalutamide Tablets Market, by Distribution Channel
11.1. Introduction
11.2. Direct Tender
11.2.1. National Tenders
11.2.2. Regional Tenders
11.3. Hospital Pharmacy Purchase
11.3.1. Direct Procurement
11.3.2. Public Tenders
11.4. Online Pharmacies
11.4.1. Manufacturer Websites
11.4.2. Third-Party Platforms
12. Enzalutamide Tablets Market, by Dosage Strength
12.1. Introduction
12.2. 120 mg
12.3. 160 mg
12.4. 40 mg
12.5. 80 mg
13. Americas Enzalutamide Tablets Market
13.1. Introduction
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. Argentina
14. Europe, Middle East & Africa Enzalutamide Tablets Market
14.1. Introduction
14.2. United Kingdom
14.3. Germany
14.4. France
14.5. Russia
14.6. Italy
14.7. Spain
14.8. United Arab Emirates
14.9. Saudi Arabia
14.10. South Africa
14.11. Denmark
14.12. Netherlands
14.13. Qatar
14.14. Finland
14.15. Sweden
14.16. Nigeria
14.17. Egypt
14.18. Turkey
14.19. Israel
14.20. Norway
14.21. Poland
14.22. Switzerland
15. Asia-Pacific Enzalutamide Tablets Market
15.1. Introduction
15.2. China
15.3. India
15.4. Japan
15.5. Australia
15.6. South Korea
15.7. Indonesia
15.8. Thailand
15.9. Philippines
15.10. Malaysia
15.11. Singapore
15.12. Vietnam
15.13. Taiwan
16. Competitive Landscape
16.1. Market Share Analysis, 2024
16.2. FPNV Positioning Matrix, 2024
16.3. Competitive Analysis
16.3.1. Astellas Pharma Inc.
16.3.2. Pfizer Inc.
16.3.3. Teva Pharmaceutical Industries Ltd.
16.3.4. Sandoz International GmbH
16.3.5. Dr. Reddy’s Laboratories Ltd.
16.3.6. Aurobindo Pharma Ltd.
16.3.7. Sun Pharmaceutical Industries Ltd.
16.3.8. Lupin Limited
16.3.9. Cipla Limited
16.3.10. Hetero Labs Limited
17. ResearchAI
18. ResearchStatistics
19. ResearchContacts
20. ResearchArticles
21. Appendix
List of Figures
FIGURE 1. ENZALUTAMIDE TABLETS MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL ENZALUTAMIDE TABLETS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL ENZALUTAMIDE TABLETS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL ENZALUTAMIDE TABLETS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL ENZALUTAMIDE TABLETS MARKET SIZE, BY THERAPY LINE, 2024 VS 2030 (%)
FIGURE 6. GLOBAL ENZALUTAMIDE TABLETS MARKET SIZE, BY THERAPY LINE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL ENZALUTAMIDE TABLETS MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 8. GLOBAL ENZALUTAMIDE TABLETS MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL ENZALUTAMIDE TABLETS MARKET SIZE, BY INDICATION, 2024 VS 2030 (%)
FIGURE 10. GLOBAL ENZALUTAMIDE TABLETS MARKET SIZE, BY INDICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL ENZALUTAMIDE TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 12. GLOBAL ENZALUTAMIDE TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL ENZALUTAMIDE TABLETS MARKET SIZE, BY DOSAGE STRENGTH, 2024 VS 2030 (%)
FIGURE 14. GLOBAL ENZALUTAMIDE TABLETS MARKET SIZE, BY DOSAGE STRENGTH, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS ENZALUTAMIDE TABLETS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 16. AMERICAS ENZALUTAMIDE TABLETS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES ENZALUTAMIDE TABLETS MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 18. UNITED STATES ENZALUTAMIDE TABLETS MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA ENZALUTAMIDE TABLETS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA ENZALUTAMIDE TABLETS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC ENZALUTAMIDE TABLETS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC ENZALUTAMIDE TABLETS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. ENZALUTAMIDE TABLETS MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 24. ENZALUTAMIDE TABLETS MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 25. ENZALUTAMIDE TABLETS MARKET: RESEARCHAI
FIGURE 26. ENZALUTAMIDE TABLETS MARKET: RESEARCHSTATISTICS
FIGURE 27. ENZALUTAMIDE TABLETS MARKET: RESEARCHCONTACTS
FIGURE 28. ENZALUTAMIDE TABLETS MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. ENZALUTAMIDE TABLETS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL ENZALUTAMIDE TABLETS MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL ENZALUTAMIDE TABLETS MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL ENZALUTAMIDE TABLETS MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL ENZALUTAMIDE TABLETS MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL ENZALUTAMIDE TABLETS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL ENZALUTAMIDE TABLETS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL ENZALUTAMIDE TABLETS MARKET SIZE, BY THERAPY LINE, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL ENZALUTAMIDE TABLETS MARKET SIZE, BY THERAPY LINE, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL ENZALUTAMIDE TABLETS MARKET SIZE, BY FIRST-LINE THERAPY, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL ENZALUTAMIDE TABLETS MARKET SIZE, BY FIRST-LINE THERAPY, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL ENZALUTAMIDE TABLETS MARKET SIZE, BY SECOND-LINE THERAPY, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL ENZALUTAMIDE TABLETS MARKET SIZE, BY SECOND-LINE THERAPY, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL ENZALUTAMIDE TABLETS MARKET SIZE, BY THIRD-LINE THERAPY, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL ENZALUTAMIDE TABLETS MARKET SIZE, BY THIRD-LINE THERAPY, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL ENZALUTAMIDE TABLETS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL ENZALUTAMIDE TABLETS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL ENZALUTAMIDE TABLETS MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL ENZALUTAMIDE TABLETS MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL ENZALUTAMIDE TABLETS MARKET SIZE, BY GOVERNMENT HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL ENZALUTAMIDE TABLETS MARKET SIZE, BY GOVERNMENT HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL ENZALUTAMIDE TABLETS MARKET SIZE, BY PRIVATE HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL ENZALUTAMIDE TABLETS MARKET SIZE, BY PRIVATE HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL ENZALUTAMIDE TABLETS MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL ENZALUTAMIDE TABLETS MARKET SIZE, BY HOSPITAL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL ENZALUTAMIDE TABLETS MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL ENZALUTAMIDE TABLETS MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL ENZALUTAMIDE TABLETS MARKET SIZE, BY CHAIN PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL ENZALUTAMIDE TABLETS MARKET SIZE, BY CHAIN PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL ENZALUTAMIDE TABLETS MARKET SIZE, BY INDEPENDENT PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL ENZALUTAMIDE TABLETS MARKET SIZE, BY INDEPENDENT PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL ENZALUTAMIDE TABLETS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL ENZALUTAMIDE TABLETS MARKET SIZE, BY RETAIL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL ENZALUTAMIDE TABLETS MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL ENZALUTAMIDE TABLETS MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL ENZALUTAMIDE TABLETS MARKET SIZE, BY ONCOLOGY CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL ENZALUTAMIDE TABLETS MARKET SIZE, BY ONCOLOGY CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL ENZALUTAMIDE TABLETS MARKET SIZE, BY UROLOGY CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL ENZALUTAMIDE TABLETS MARKET SIZE, BY UROLOGY CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL ENZALUTAMIDE TABLETS MARKET SIZE, BY SPECIALTY CLINICS, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL ENZALUTAMIDE TABLETS MARKET SIZE, BY SPECIALTY CLINICS, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL ENZALUTAMIDE TABLETS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL ENZALUTAMIDE TABLETS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL ENZALUTAMIDE TABLETS MARKET SIZE, BY METASTATIC CASTRATION-RESISTANT PROSTATE CANCER, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL ENZALUTAMIDE TABLETS MARKET SIZE, BY METASTATIC CASTRATION-RESISTANT PROSTATE CANCER, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL ENZALUTAMIDE TABLETS MARKET SIZE, BY METASTATIC HORMONE-SENSITIVE PROSTATE CANCER, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL ENZALUTAMIDE TABLETS MARKET SIZE, BY METASTATIC HORMONE-SENSITIVE PROSTATE CANCER, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL ENZALUTAMIDE TABLETS MARKET SIZE, BY NON-METASTATIC CASTRATION-RESISTANT PROSTATE CANCER, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL ENZALUTAMIDE TABLETS MARKET SIZE, BY NON-METASTATIC CASTRATION-RESISTANT PROSTATE CANCER, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL ENZALUTAMIDE TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL ENZALUTAMIDE TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL ENZALUTAMIDE TABLETS MARKET SIZE, BY DIRECT TENDER, BY REGION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL ENZALUTAMIDE TABLETS MARKET SIZE, BY DIRECT TENDER, BY REGION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL ENZALUTAMIDE TABLETS MARKET SIZE, BY NATIONAL TENDERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL ENZALUTAMIDE TABLETS MARKET SIZE, BY NATIONAL TENDERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL ENZALUTAMIDE TABLETS MARKET SIZE, BY REGIONAL TENDERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL ENZALUTAMIDE TABLETS MARKET SIZE, BY REGIONAL TENDERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL ENZALUTAMIDE TABLETS MARKET SIZE, BY DIRECT TENDER, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL ENZALUTAMIDE TABLETS MARKET SIZE, BY DIRECT TENDER, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL ENZALUTAMIDE TABLETS MARKET SIZE, BY HOSPITAL PHARMACY PURCHASE, BY REGION, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL ENZALUTAMIDE TABLETS MARKET SIZE, BY HOSPITAL PHARMACY PURCHASE, BY REGION, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL ENZALUTAMIDE TABLETS MARKET SIZE, BY DIRECT PROCUREMENT, BY REGION, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL ENZALUTAMIDE TABLETS MARKET SIZE, BY DIRECT PROCUREMENT, BY REGION, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL ENZALUTAMIDE TABLETS MARKET SIZE, BY PUBLIC TENDERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL ENZALUTAMIDE TABLETS MARKET SIZE, BY PUBLIC TENDERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL ENZALUTAMIDE TABLETS MARKET SIZE, BY HOSPITAL PHARMACY PURCHASE, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL ENZALUTAMIDE TABLETS MARKET SIZE, BY HOSPITAL PHARMACY PURCHASE, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL ENZALUTAMIDE TABLETS MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL ENZALUTAMIDE TABLETS MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 71. GLOBAL ENZALUTAMIDE TABLETS MARKET SIZE, BY MANUFACTURER WEBSITES, BY REGION, 2018-2024 (USD MILLION)
TABLE 72. GLOBAL ENZALUTAMIDE TABLETS MARKET SIZE, BY MANUFACTURER WEBSITES, BY REGION, 2025-2030 (USD MILLION)
TABLE 73. GLOBAL ENZALUTAMIDE TABLETS MARKET SIZE, BY THIRD-PARTY PLATFORMS, BY REGION, 2018-2024 (USD MILLION)
TABLE 74. GLOBAL ENZALUTAMIDE TABLETS MARKET SIZE, BY THIRD-PARTY PLATFORMS, BY REGION, 2025-2030 (USD MILLION)
TABLE 75. GLOBAL ENZALUTAMIDE TABLETS MARKET SIZE, BY ONLINE PHARMACIES, 2018-2024 (USD MILLION)
TABLE 76. GLOBAL ENZALUTAMIDE TABLETS MARKET SIZE, BY ONLINE PHARMACIES, 2025-2030 (USD MILLION)
TABLE 77. GLOBAL ENZALUTAMIDE TABLETS MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 78. GLOBAL ENZALUTAMIDE TABLETS MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 79. GLOBAL ENZALUTAMIDE TABLETS MARKET SIZE, BY 120 MG, BY REGION, 2018-2024 (USD MILLION)
TABLE 80. GLOBAL ENZALUTAMIDE TABLETS MARKET SIZE, BY 120 MG, BY REGION, 2025-2030 (USD MILLION)
TABLE 81. GLOBAL ENZALUTAMIDE TABLETS MARKET SIZE, BY 160 MG, BY REGION, 2018-2024 (USD MILLION)
TABLE 82. GLOBAL ENZALUTAMIDE TABLETS MARKET SIZE, BY 160 MG, BY REGION, 2025-2030 (USD MILLION)
TABLE 83. GLOBAL ENZALUTAMIDE TABLETS MARKET SIZE, BY 40 MG, BY REGION, 2018-2024 (USD MILLION)
TABLE 84. GLOBAL ENZALUTAMIDE TABLETS MARKET SIZE, BY 40 MG, BY REGION, 2025-2030 (USD MILLION)
TABLE 85. GLOBAL ENZALUTAMIDE TABLETS MARKET SIZE, BY 80 MG, BY REGION, 2018-2024 (USD MILLION)
TABLE 86. GLOBAL ENZALUTAMIDE TABLETS MARKET SIZE, BY 80 MG, BY REGION, 2025-2030 (USD MILLION)
TABLE 87. AMERICAS ENZALUTAMIDE TABLETS MARKET SIZE, BY THERAPY LINE, 2018-2024 (USD MILLION)
TABLE 88. AMERICAS ENZALUTAMIDE TABLETS MARKET SIZE, BY THERAPY LINE, 2025-2030 (USD MILLION)
TABLE 89. AMERICAS ENZALUTAMIDE TABLETS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 90. AMERICAS ENZALUTAMIDE TABLETS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 91. AMERICAS ENZALUTAMIDE TABLETS MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 92. AMERICAS ENZALUTAMIDE TABLETS MARKET SIZE, BY HOSPITAL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 93. AMERICAS ENZALUTAMIDE TABLETS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 94. AMERICAS ENZALUTAMIDE TABLETS MARKET SIZE, BY RETAIL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 95. AMERICAS ENZALUTAMIDE TABLETS MARKET SIZE, BY SPECIALTY CLINICS, 2018-2024 (USD MILLION)
TABLE 96. AMERICAS ENZALUTAMIDE TABLETS MARKET SIZE, BY SPECIALTY CLINICS, 2025-2030 (USD MILLION)
TABLE 97. AMERICAS ENZALUTAMIDE TABLETS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 98. AMERICAS ENZALUTAMIDE TABLETS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 99. AMERICAS ENZALUTAMIDE TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 100. AMERICAS ENZALUTAMIDE TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 101. AMERICAS ENZALUTAMIDE TABLETS MARKET SIZE, BY DIRECT TENDER, 2018-2024 (USD MILLION)
TABLE 102. AMERICAS ENZALUTAMIDE TABLETS MARKET SIZE, BY DIRECT TENDER, 2025-2030 (USD MILLION)
TABLE 103. AMERICAS ENZALUTAMIDE TABLETS MARKET SIZE, BY HOSPITAL PHARMACY PURCHASE, 2018-2024 (USD MILLION)
TABLE 104. AMERICAS ENZALUTAMIDE TABLETS MARKET SIZE, BY HOSPITAL PHARMACY PURCHASE, 2025-2030 (USD MILLION)
TABLE 105. AMERICAS ENZALUTAMIDE TABLETS MARKET SIZE, BY ONLINE PHARMACIES, 2018-2024 (USD MILLION)
TABLE 106. AMERICAS ENZALUTAMIDE TABLETS MARKET SIZE, BY ONLINE PHARMACIES, 2025-2030 (USD MILLION)
TABLE 107. AMERICAS ENZALUTAMIDE TABLETS MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 108. AMERICAS ENZALUTAMIDE TABLETS MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 109. AMERICAS ENZALUTAMIDE TABLETS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 110. AMERICAS ENZALUTAMIDE TABLETS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 111. UNITED STATES ENZALUTAMIDE TABLETS MARKET SIZE, BY THERAPY LINE, 2018-2024 (USD MILLION)
TABLE 112. UNITED STATES ENZALUTAMIDE TABLETS MARKET SIZE, BY THERAPY LINE, 2025-2030 (USD MILLION)
TABLE 113. UNITED STATES ENZALUTAMIDE TABLETS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 114. UNITED STATES ENZALUTAMIDE TABLETS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 115. UNITED STATES ENZALUTAMIDE TABLETS MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 116. UNITED STATES ENZALUTAMIDE TABLETS MARKET SIZE, BY HOSPITAL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 117. UNITED STATES ENZALUTAMIDE TABLETS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 118. UNITED STATES ENZALUTAMIDE TABLETS MARKET SIZE, BY RETAIL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 119. UNITED STATES ENZALUTAMIDE TABLETS MARKET SIZE, BY SPECIALTY CLINICS, 2018-2024 (USD MILLION)
TABLE 120. UNITED STATES ENZALUTAMIDE TABLETS MARKET SIZE, BY SPECIALTY CLINICS, 2025-2030 (USD MILLION)
TABLE 121. UNITED STATES ENZALUTAMIDE TABLETS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 122. UNITED STATES ENZALUTAMIDE TABLETS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 123. UNITED STATES ENZALUTAMIDE TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 124. UNITED STATES ENZALUTAMIDE TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 125. UNITED STATES ENZALUTAMIDE TABLETS MARKET SIZE, BY DIRECT TENDER, 2018-2024 (USD MILLION)
TABLE 126. UNITED STATES ENZALUTAMIDE TABLETS MARKET SIZE, BY DIRECT TENDER, 2025-2030 (USD MILLION)
TABLE 127. UNITED STATES ENZALUTAMIDE TABLETS MARKET SIZE, BY HOSPITAL PHARMACY PURCHASE, 2018-2024 (USD MILLION)
TABLE 128. UNITED STATES ENZALUTAMIDE TABLETS MARKET SIZE, BY HOSPITAL PHARMACY PURCHASE, 2025-2030 (USD MILLION)
TABLE 129. UNITED STATES ENZALUTAMIDE TABLETS MARKET SIZE, BY ONLINE PHARMACIES, 2018-2024 (USD MILLION)
TABLE 130. UNITED STATES ENZALUTAMIDE TABLETS MARKET SIZE, BY ONLINE PHARMACIES, 2025-2030 (USD MILLION)
TABLE 131. UNITED STATES ENZALUTAMIDE TABLETS MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 132. UNITED STATES ENZALUTAMIDE TABLETS MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 133. UNITED STATES ENZALUTAMIDE TABLETS MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 134. UNITED STATES ENZALUTAMIDE TABLETS MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 135. CANADA ENZALUTAMIDE TABLETS MARKET SIZE, BY THERAPY LINE, 2018-2024 (USD MILLION)
TABLE 136. CANADA ENZALUTAMIDE TABLETS MARKET SIZE, BY THERAPY LINE, 2025-2030 (USD MILLION)
TABLE 137. CANADA ENZALUTAMIDE TABLETS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 138. CANADA ENZALUTAMIDE TABLETS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 139. CANADA ENZALUTAMIDE TABLETS MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 140. CANADA ENZALUTAMIDE TABLETS MARKET SIZE, BY HOSPITAL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 141. CANADA ENZALUTAMIDE TABLETS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 142. CANADA ENZALUTAMIDE TABLETS MARKET SIZE, BY RETAIL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 143. CANADA ENZALUTAMIDE TABLETS MARKET SIZE, BY SPECIALTY CLINICS, 2018-2024 (USD MILLION)
TABLE 144. CANADA ENZALUTAMIDE TABLETS MARKET SIZE, BY SPECIALTY CLINICS, 2025-2030 (USD MILLION)
TABLE 145. CANADA ENZALUTAMIDE TABLETS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 146. CANADA ENZALUTAMIDE TABLETS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 147. CANADA ENZALUTAMIDE TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 148. CANADA ENZALUTAMIDE TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 149. CANADA ENZALUTAMIDE TABLETS MARKET SIZE, BY DIRECT TENDER, 2018-2024 (USD MILLION)
TABLE 150. CANADA ENZALUTAMIDE TABLETS MARKET SIZE, BY DIRECT TENDER, 2025-2030 (USD MILLION)
TABLE 151. CANADA ENZALUTAMIDE TABLETS MARKET SIZE, BY HOSPITAL PHARMACY PURCHASE, 2018-2024 (USD MILLION)
TABLE 152. CANADA ENZALUTAMIDE TABLETS MARKET SIZE, BY HOSPITAL PHARMACY PURCHASE, 2025-2030 (USD MILLION)
TABLE 153. CANADA ENZALUTAMIDE TABLETS MARKET SIZE, BY ONLINE PHARMACIES, 2018-2024 (USD MILLION)
TABLE 154. CANADA ENZALUTAMIDE TABLETS MARKET SIZE, BY ONLINE PHARMACIES, 2025-2030 (USD MILLION)
TABLE 155. CANADA ENZALUTAMIDE TABLETS MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 156. CANADA ENZALUTAMIDE TABLETS MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 157. MEXICO ENZALUTAMIDE TABLETS MARKET SIZE, BY THERAPY LINE, 2018-2024 (USD MILLION)
TABLE 158. MEXICO ENZALUTAMIDE TABLETS MARKET SIZE, BY THERAPY LINE, 2025-2030 (USD MILLION)
TABLE 159. MEXICO ENZALUTAMIDE TABLETS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 160. MEXICO ENZALUTAMIDE TABLETS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 161. MEXICO ENZALUTAMIDE TABLETS MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 162. MEXICO ENZALUTAMIDE TABLETS MARKET SIZE, BY HOSPITAL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 163. MEXICO ENZALUTAMIDE TABLETS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 164. MEXICO ENZALUTAMIDE TABLETS MARKET SIZE, BY RETAIL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 165. MEXICO ENZALUTAMIDE TABLETS MARKET SIZE, BY SPECIALTY CLINICS, 2018-2024 (USD MILLION)
TABLE 166. MEXICO ENZALUTAMIDE TABLETS MARKET SIZE, BY SPECIALTY CLINICS, 2025-2030 (USD MILLION)
TABLE 167. MEXICO ENZALUTAMIDE TABLETS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 168. MEXICO ENZALUTAMIDE TABLETS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 169. MEXICO ENZALUTAMIDE TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 170. MEXICO ENZALUTAMIDE TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 171. MEXICO ENZALUTAMIDE TABLETS MARKET SIZE, BY DIRECT TENDER, 2018-2024 (USD MILLION)
TABLE 172. MEXICO ENZALUTAMIDE TABLETS MARKET SIZE, BY DIRECT TENDER, 2025-2030 (USD MILLION)
TABLE 173. MEXICO ENZALUTAMIDE TABLETS MARKET SIZE, BY HOSPITAL PHARMACY PURCHASE, 2018-2024 (USD MILLION)
TABLE 174. MEXICO ENZALUTAMIDE TABLETS MARKET SIZE, BY HOSPITAL PHARMACY PURCHASE, 2025-2030 (USD MILLION)
TABLE 175. MEXICO ENZALUTAMIDE TABLETS MARKET SIZE, BY ONLINE PHARMACIES, 2018-2024 (USD MILLION)
TABLE 176. MEXICO ENZALUTAMIDE TABLETS MARKET SIZE, BY ONLINE PHARMACIES, 2025-2030 (USD MILLION)
TABLE 177. MEXICO ENZALUTAMIDE TABLETS MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 178. MEXICO ENZALUTAMIDE TABLETS MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 179. BRAZIL ENZALUTAMIDE TABLETS MARKET SIZE, BY THERAPY LINE, 2018-2024 (USD MILLION)
TABLE 180. BRAZIL ENZALUTAMIDE TABLETS MARKET SIZE, BY THERAPY LINE, 2025-2030 (USD MILLION)
TABLE 181. BRAZIL ENZALUTAMIDE TABLETS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 182. BRAZIL ENZALUTAMIDE TABLETS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 183. BRAZIL ENZALUTAMIDE TABLETS MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 184. BRAZIL ENZALUTAMIDE TABLETS MARKET SIZE, BY HOSPITAL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 185. BRAZIL ENZALUTAMIDE TABLETS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 186. BRAZIL ENZALUTAMIDE TABLETS MARKET SIZE, BY RETAIL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 187. BRAZIL ENZALUTAMIDE TABLETS MARKET SIZE, BY SPECIALTY CLINICS, 2018-2024 (USD MILLION)
TABLE 188. BRAZIL ENZALUTAMIDE TABLETS MARKET SIZE, BY SPECIALTY CLINICS, 2025-2030 (USD MILLION)
TABLE 189. BRAZIL ENZALUTAMIDE TABLETS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 190. BRAZIL ENZALUTAMIDE TABLETS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 191. BRAZIL ENZALUTAMIDE TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 192. BRAZIL ENZALUTAMIDE TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 193. BRAZIL ENZALUTAMIDE TABLETS MARKET SIZE, BY DIRECT TENDER, 2018-2024 (USD MILLION)
TABLE 194. BRAZIL ENZALUTAMIDE TABLETS MARKET SIZE, BY DIRECT TENDER, 2025-2030 (USD MILLION)
TABLE 195. BRAZIL ENZALUTAMIDE TABLETS MARKET SIZE, BY HOSPITAL PHARMACY PURCHASE, 2018-2024 (USD MILLION)
TABLE 196. BRAZIL ENZALUTAMIDE TABLETS MARKET SIZE, BY HOSPITAL PHARMACY PURCHASE, 2025-2030 (USD MILLION)
TABLE 197. BRAZIL ENZALUTAMIDE TABLETS MARKET SIZE, BY ONLINE PHARMACIES, 2018-2024 (USD MILLION)
TABLE 198. BRAZIL ENZALUTAMIDE TABLETS MARKET SIZE, BY ONLINE PHARMACIES, 2025-2030 (USD MILLION)
TABLE 199. BRAZIL ENZALUTAMIDE TABLETS MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 200. BRAZIL ENZALUTAMIDE TABLETS MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 201. ARGENTINA ENZALUTAMIDE TABLETS MARKET SIZE, BY THERAPY LINE, 2018-2024 (USD MILLION)
TABLE 202. ARGENTINA ENZALUTAMIDE TABLETS MARKET SIZE, BY THERAPY LINE, 2025-2030 (USD MILLION)
TABLE 203. ARGENTINA ENZALUTAMIDE TABLETS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 204. ARGENTINA ENZALUTAMIDE TABLETS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 205. ARGENTINA ENZALUTAMIDE TABLETS MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 206. ARGENTINA ENZALUTAMIDE TABLETS MARKET SIZE, BY HOSPITAL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 207. ARGENTINA ENZALUTAMIDE TABLETS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 208. ARGENTINA ENZALUTAMIDE TABLETS MARKET SIZE, BY RETAIL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 209. ARGENTINA ENZALUTAMIDE TABLETS MARKET SIZE, BY SPECIALTY CLINICS, 2018-2024 (USD MILLION)
TABLE 210. ARGENTINA ENZALUTAMIDE TABLETS MARKET SIZE, BY SPECIALTY CLINICS, 2025-2030 (USD MILLION)
TABLE 211. ARGENTINA ENZALUTAMIDE TABLETS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 212. ARGENTINA ENZALUTAMIDE TABLETS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 213. ARGENTINA ENZALUTAMIDE TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 214. ARGENTINA ENZALUTAMIDE TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 215. ARGENTINA ENZALUTAMIDE TABLETS MARKET SIZE, BY DIRECT TENDER, 2018-2024 (USD MILLION)
TABLE 216. ARGENTINA ENZALUTAMIDE TABLETS MARKET SIZE, BY DIRECT TENDER, 2025-2030 (USD MILLION)
TABLE 217. ARGENTINA ENZALUTAMIDE TABLETS MARKET SIZE, BY HOSPITAL PHARMACY PURCHASE, 2018-2024 (USD MILLION)
TABLE 218. ARGENTINA ENZALUTAMIDE TABLETS MARKET SIZE, BY HOSPITAL PHARMACY PURCHASE, 2025-2030 (USD MILLION)
TABLE 219. ARGENTINA ENZALUTAMIDE TABLETS MARKET SIZE, BY ONLINE PHARMACIES, 2018-2024 (USD MILLION)
TABLE 220. ARGENTINA ENZALUTAMIDE TABLETS MARKET SIZE, BY ONLINE PHARMACIES, 2025-2030 (USD MILLION)
TABLE 221. ARGENTINA ENZALUTAMIDE TABLETS MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 222. ARGENTINA ENZALUTAMIDE TABLETS MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 223. EUROPE, MIDDLE EAST & AFRICA ENZALUTAMIDE TABLETS MARKET SIZE, BY THERAPY LINE, 2018-2024 (USD MILLION)
TABLE 224. EUROPE, MIDDLE EAST & AFRICA ENZALUTAMIDE TABLETS MARKET SIZE, BY THERAPY LINE, 2025-2030 (USD MILLION)
TABLE 225. EUROPE, MIDDLE EAST & AFRICA ENZALUTAMIDE TABLETS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 226. EUROPE, MIDDLE EAST & AFRICA ENZALUTAMIDE TABLETS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 227. EUROPE, MIDDLE EAST & AFRICA ENZALUTAMIDE TABLETS MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 228. EUROPE, MIDDLE EAST & AFRICA ENZALUTAMIDE TABLETS MARKET SIZE, BY HOSPITAL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 229. EUROPE, MIDDLE EAST & AFRICA ENZALUTAMIDE TABLETS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 230. EUROPE, MIDDLE EAST & AFRICA ENZALUTAMIDE TABLETS MARKET SIZE, BY RETAIL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 231. EUROPE, MIDDLE EAST & AFRICA ENZALUTAMIDE TABLETS MARKET SIZE, BY SPECIALTY CLINICS, 2018-2024 (USD MILLION)
TABLE 232. EUROPE, MIDDLE EAST & AFRICA ENZALUTAMIDE TABLETS MARKET SIZE, BY SPECIALTY CLINICS, 2025-2030 (USD MILLION)
TABLE 233. EUROPE, MIDDLE EAST & AFRICA ENZALUTAMIDE TABLETS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 234. EUROPE, MIDDLE EAST & AFRICA ENZALUTAMIDE TABLETS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 235. EUROPE, MIDDLE EAST & AFRICA ENZALUTAMIDE TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 236. EUROPE, MIDDLE EAST & AFRICA ENZALUTAMIDE TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 237. EUROPE, MIDDLE EAST & AFRICA ENZALUTAMIDE TABLETS MARKET SIZE, BY DIRECT TENDER, 2018-2024 (USD MILLION)
TABLE 238. EUROPE, MIDDLE EAST & AFRICA ENZALUTAMIDE TABLETS MARKET SIZE, BY DIRECT TENDER, 2025-2030 (USD MILLION)
TABLE 239. EUROPE, MIDDLE EAST & AFRICA ENZALUTAMIDE TABLETS MARKET SIZE, BY HOSPITAL PHARMACY PURCHASE, 2018-2024 (USD MILLION)
TABLE 240. EUROPE, MIDDLE EAST & AFRICA ENZALUTAMIDE TABLETS MARKET SIZE, BY HOSPITAL PHARMACY PURCHASE, 2025-2030 (USD MILLION)
TABLE 241. EUROPE, MIDDLE EAST & AFRICA ENZALUTAMIDE TABLETS MARKET SIZE, BY ONLINE PHARMACIES, 2018-2024 (USD MILLION)
TABLE 242. EUROPE, MIDDLE EAST & AFRICA ENZALUTAMIDE TABLETS MARKET SIZE, BY ONLINE PHARMACIES, 2025-2030 (USD MILLION)
TABLE 243. EUROPE, MIDDLE EAST & AFRICA ENZALUTAMIDE TABLETS MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 244. EUROPE, MIDDLE EAST & AFRICA ENZALUTAMIDE TABLETS MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 245. EUROPE, MIDDLE EAST & AFRICA ENZALUTAMIDE TABLETS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 246. EUROPE, MIDDLE EAST & AFRICA ENZALUTAMIDE TABLETS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 247. UNITED KINGDOM ENZALUTAMIDE TABLETS MARKET SIZE, BY THERAPY LINE, 2018-2024 (USD MILLION)
TABLE 248. UNITED KINGDOM ENZALUTAMIDE TABLETS MARKET SIZE, BY THERAPY LINE, 2025-2030 (USD MILLION)
TABLE 249. UNITED KINGDOM ENZALUTAMIDE TABLETS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 250. UNITED KINGDOM ENZALUTAMIDE TABLETS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 251. UNITED KINGDOM ENZALUTAMIDE TABLETS MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 252. UNITED KINGDOM ENZALUTAMIDE TABLETS MARKET SIZE, BY HOSPITAL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 253. UNITED KINGDOM ENZALUTAMIDE TABLETS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 254. UNITED KINGDOM ENZALUTAMIDE TABLETS MARKET SIZE, BY RETAIL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 255. UNITED KINGDOM ENZALUTAMIDE TABLETS MARKET SIZE, BY SPECIALTY CLINICS, 2018-2024 (USD MILLION)
TABLE 256. UNITED KINGDOM ENZALUTAMIDE TABLETS MARKET SIZE, BY SPECIALTY CLINICS, 2025-2030 (USD MILLION)
TABLE 257. UNITED KINGDOM ENZALUTAMIDE TABLETS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 258. UNITED KINGDOM ENZALUTAMIDE TABLETS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 259. UNITED KINGDOM ENZALUTAMIDE TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 260. UNITED KINGDOM ENZALUTAMIDE TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 261. UNITED KINGDOM ENZALUTAMIDE TABLETS MARKET SIZE, BY DIRECT TENDER, 2018-2024 (USD MILLION)
TABLE 262. UNITED KINGDOM ENZALUTAMIDE TABLETS MARKET SIZE, BY DIRECT TENDER, 2025-2030 (USD MILLION)
TABLE 263. UNITED KINGDOM ENZALUTAMIDE TABLETS MARKET SIZE, BY HOSPITAL PHARMACY PURCHASE, 2018-2024 (USD MILLION)
TABLE 264. UNITED KINGDOM ENZALUTAMIDE TABLETS MARKET SIZE, BY HOSPITAL PHARMACY PURCHASE, 2025-2030 (USD MILLION)
TABLE 265. UNITED KINGDOM ENZALUTAMIDE TABLETS MARKET SIZE, BY ONLINE PHARMACIES, 2018-2024 (USD MILLION)
TABLE 266. UNITED KINGDOM ENZALUTAMIDE TABLETS MARKET SIZE, BY ONLINE PHARMACIES, 2025-2030 (USD MILLION)
TABLE 267. UNITED KINGDOM ENZALUTAMIDE TABLETS MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 268. UNITED KINGDOM ENZALUTAMIDE TABLETS MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 269. GERMANY ENZALUTAMIDE TABLETS MARKET SIZE, BY THERAPY LINE, 2018-2024 (USD MILLION)
TABLE 270. GERMANY ENZALUTAMIDE TABLETS MARKET SIZE, BY THERAPY LINE, 2025-2030 (USD MILLION)
TABLE 271. GERMANY ENZALUTAMIDE TABLETS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 272. GERMANY ENZALUTAMIDE TABLETS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 273. GERMANY ENZALUTAMIDE TABLETS MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 274. GERMANY ENZALUTAMIDE TABLETS MARKET SIZE, BY HOSPITAL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 275. GERMANY ENZALUTAMIDE TABLETS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 276. GERMANY ENZALUTAMIDE TABLETS MARKET SIZE, BY RETAIL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 277. GERMANY ENZALUTAMIDE TABLETS MARKET SIZE, BY SPECIALTY CLINICS, 2018-2024 (USD MILLION)
TABLE 278. GERMANY ENZALUTAMIDE TABLETS MARKET SIZE, BY SPECIALTY CLINICS, 2025-2030 (USD MILLION)
TABLE 279. GERMANY ENZALUTAMIDE TABLETS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 280. GERMANY ENZALUTAMIDE TABLETS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 281. GERMANY ENZALUTAMIDE TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 282. GERMANY ENZALUTAMIDE TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 283. GERMANY ENZALUTAMIDE TABLETS MARKET SIZE, BY DIRECT TENDER, 2018-2024 (USD MILLION)
TABLE 284. GERMANY ENZALUTAMIDE TABLETS MARKET SIZE, BY DIRECT TENDER, 2025-2030 (USD MILLION)
TABLE 285. GERMANY ENZALUTAMIDE TABLETS MARKET SIZE, BY HOSPITAL PHARMACY PURCHASE, 2018-2024 (USD MILLION)
TABLE 286. GERMANY ENZALUTAMIDE TABLETS MARKET SIZE, BY HOSPITAL PHARMACY PURCHASE, 2025-2030 (USD MILLION)
TABLE 287. GERMANY ENZALUTAMIDE TABLETS MARKET SIZE, BY ONLINE PHARMACIES, 2018-2024 (USD MILLION)
TABLE 288. GERMANY ENZALUTAMIDE TABLETS MARKET SIZE, BY ONLINE PHARMACIES, 2025-2030 (USD MILLION)
TABLE 289. GERMANY ENZALUTAMIDE TABLETS MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 290. GERMANY ENZALUTAMIDE TABLETS MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 291. FRANCE ENZALUTAMIDE TABLETS MARKET SIZE, BY THERAPY LINE, 2018-2024 (USD MILLION)
TABLE 292. FRANCE ENZALUTAMIDE TABLETS MARKET SIZE, BY THERAPY LINE, 2025-2030 (USD MILLION)
TABLE 293. FRANCE ENZALUTAMIDE TABLETS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 294. FRANCE ENZALUTAMIDE TABLETS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 295. FRANCE ENZALUTAMIDE TABLETS MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 296. FRANCE ENZALUTAMIDE TABLETS MARKET SIZE, BY HOSPITAL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 297. FRANCE ENZALUTAMIDE TABLETS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 298. FRANCE ENZALUTAMIDE TABLETS MARKET SIZE, BY RETAIL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 299. FRANCE ENZALUTAMIDE TABLETS MARKET SIZE, BY SPECIALTY CLINICS, 2018-2024 (USD MILLION)
TABLE 300. FRANCE ENZALUTAMIDE TABLETS MARKET SIZE, BY SPECIALTY CLINICS, 2025-2030 (USD MILLION)
TABLE 301. FRANCE ENZALUTAMIDE TABLETS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 302. FRANCE ENZALUTAMIDE TABLETS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 303. FRANCE ENZALUTAMIDE TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 304. FRANCE ENZALUTAMIDE TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 305. FRANCE ENZALUTAMIDE TABLETS MARKET SIZE, BY DIRECT TENDER, 2018-2024 (USD MILLION)
TABLE 306. FRANCE ENZALUTAMIDE TABLETS MARKET SIZE, BY DIRECT TENDER, 2025-2030 (USD MILLION)
TABLE 307. FRANCE ENZALUTAMIDE TABLETS MARKET SIZE, BY HOSPITAL PHARMACY PURCHASE, 2018-2024 (USD MILLION)
TABLE 308. FRANCE ENZALUTAMIDE TABLETS MARKET SIZE, BY HOSPITAL PHARMACY PURCHASE, 2025-2030 (USD MILLION)
TABLE 309. FRANCE ENZALUTAMIDE TABLETS MARKET SIZE, BY ONLINE PHARMACIES, 2018-2024 (USD MILLION)
TABLE 310. FRANCE ENZALUTAMIDE TABLETS MARKET SIZE, BY ONLINE PHARMACIES, 2025-2030 (USD MILLION)
TABLE 311. FRANCE ENZALUTAMIDE TABLETS MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 312. FRANCE ENZALUTAMIDE TABLETS MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 313. RUSSIA ENZALUTAMIDE TABLETS MARKET SIZE, BY THERAPY LINE, 2018-2024 (USD MILLION)
TABLE 314. RUSSIA ENZALUTAMIDE TABLETS MARKET SIZE, BY THERAPY LINE, 2025-2030 (USD MILLION)
TABLE 315. RUSSIA ENZALUTAMIDE TABLETS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 316. RUSSIA ENZALUTAMIDE TABLETS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 317. RUSSIA ENZALUTAMIDE TABLETS MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 318. RUSSIA ENZALUTAMIDE TABLETS MARKET SIZE, BY HOSPITAL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 319. RUSSIA ENZALUTAMIDE TABLETS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 320. RUSSIA ENZALUTAMIDE TABLETS MARKET SIZE, BY RETAIL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 321. RUSSIA ENZALUTAMIDE TABLETS MARKET SIZE, BY SPECIALTY CLINICS, 2018-2024 (USD MILLION)
TABLE 322. RUSSIA ENZALUTAMIDE TABLETS MARKET SIZE, BY SPECIALTY CLINICS, 2025-2030 (USD MILLION)
TABLE 323. RUSSIA ENZALUTAMIDE TABLETS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 324.

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Enzalutamide Tablets market report include:
  • Astellas Pharma Inc.
  • Pfizer Inc.
  • Teva Pharmaceutical Industries Ltd.
  • Sandoz International GmbH
  • Dr. Reddy’s Laboratories Ltd.
  • Aurobindo Pharma Ltd.
  • Sun Pharmaceutical Industries Ltd.
  • Lupin Limited
  • Cipla Limited
  • Hetero Labs Limited

Related Topics

Related Reports

Enzalutamide Drugs Market - Global Forecast 2025-2030 - Product Image

Enzalutamide Drugs Market - Global Forecast 2025-2030

  • Report
  • 187 Pages
  • Global
From
Enzalutamide Soft Capsules Market - Global Forecast 2025-2030 - Product Image

Enzalutamide Soft Capsules Market - Global Forecast 2025-2030

  • Report
  • 195 Pages
  • Global
From
Nimesulide Dispersible Tablet Global Market Report 2025 - Product Image

Nimesulide Dispersible Tablet Global Market Report 2025

  • Report
  • 175 Pages
  • Global
From
Isosorbide Mononitrate Tablet Global Market Report 2025 - Product Image

Isosorbide Mononitrate Tablet Global Market Report 2025

  • Report
  • 175 Pages
  • Global
From
Tramadol Hydrochloride Tablet Market Report: Trends, Forecast and Competitive Analysis to 2031 - Product Image

Tramadol Hydrochloride Tablet Market Report: Trends, Forecast and Competitive Analysis to 2031

  • Report
  • 150 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.